0001144204-19-031915.txt : 20190621 0001144204-19-031915.hdr.sgml : 20190621 20190621170121 ACCESSION NUMBER: 0001144204-19-031915 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190620 FILED AS OF DATE: 20190621 DATE AS OF CHANGE: 20190621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: He Wei-Wu CENTRAL INDEX KEY: 0001542073 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20713 FILM NUMBER: 19912243 MAIL ADDRESS: STREET 1: ENTREMED, INC. STREET 2: 9640 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000895051 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581959440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-864-2600 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ENTREMED INC DATE OF NAME CHANGE: 19960415 4 1 tv524053_4.xml OWNERSHIP DOCUMENT X0306 4 2019-06-20 0 0000895051 CASI Pharmaceuticals, Inc. CASI 0001542073 He Wei-Wu CASI PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DR. SUITE 300 ROCKVILLE MD 20850 1 1 1 0 CEO Stock Option (Right to Buy) 2.85 2019-06-20 4 A 0 4000000 0 A 2021-04-02 2029-04-02 Common Stock 4000000 4000000 D The option grant was approved by the Board of Directors effective April 2, 2019, subject to stockholder approval of the option grant. The Company's stockholders approved the option grant on June 20, 2019. All of the options will vest and become exercisable the earlier of (i) completion of a transformative event by the Company as determined in the discretion of the Compensation Committee or (ii) the second anniversary of the date of grant. /s/Cynthia W. Hu, attorney-in-fact for We-Wu He 2019-06-21